+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Smart Blood Glucose Monitoring Device Market by Product Type, End User, Technology, Application, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6080667
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Revolutionizing Diabetes Management Through Smart Monitoring

The management of diabetes has undergone a technological renaissance as digital health solutions converge with patient-centered care. Smart blood glucose monitoring devices have emerged as a cornerstone of this transformation, offering real-time, continuous data streams that empower individuals and clinicians to make informed treatment decisions. Beyond mere numerical readings, these devices integrate seamlessly with mobile applications and cloud-based platforms, facilitating personalized alerts, trend analysis, and remote monitoring capabilities. As a result, patients experience improved glycemic control, reduced incidence of hypoglycemic events, and enhanced quality of life.

From Reactive to Proactive: Transformative Shifts in the Landscape

In recent years, the landscape of glucose monitoring has shifted dramatically from episodic, self-administered finger-stick tests to sophisticated continuous glucose monitoring systems. This evolution reflects a broader trend toward proactive, data-driven health management that emphasizes early intervention and individualized therapy adjustments. Regulatory approvals for minimally invasive and non-invasive sensor technologies have accelerated adoption, while the rise of interoperable platforms has fostered collaboration between device manufacturers, software developers, and healthcare providers. As a result, the market is experiencing a paradigm shift in which seamless patient experiences and integrated care pathways redefine the standard of diabetes management.

Tariff Turbulence: Assessing the Cumulative Impact of U.S. Tariffs in 2025

The introduction of new tariff measures by the United States in 2025 has introduced both challenges and opportunities for global manufacturers of glucose monitoring devices. Import duties on sensors, transmitters, and complete system kits have exerted upward pressure on unit costs, prompting supply chain realignments and strategic sourcing initiatives. Many manufacturers have responded by diversifying production footprints, shifting assembly to tariff-exempt regions, and renegotiating supplier contracts to mitigate cost escalation. Conversely, some innovators have leveraged the tariff environment to accelerate local manufacturing partnerships and secure preferential procurement agreements with major healthcare networks.

Unveiling Market Segmentation Insights That Drive Growth

A nuanced examination of market segments reveals distinct growth trajectories and adoption drivers across product type, end user, technology, application, and distribution channel. Within product type, continuous glucose monitoring systems such as Dexcom G6, FreeStyle Libre, and Medtronic Guardian are gaining traction among patients seeking round-the-clock insights, while self-monitoring alternatives encompassing glucometers and test strips maintain a foothold in cost-sensitive cohorts. In the realm of end users, ambulatory care centres and diagnostic facilities prioritize high-precision analytics, hospitals and clinics integrate remote monitoring into telehealth programs, and home usage-spanning adult and pediatric applications-emerges as a critical frontier for patient autonomy. Technological innovation continues to drive differentiation, with invasive sensors delivering uncompromised accuracy, minimally invasive patches reducing patient discomfort, and emerging non-invasive options promising needle-free convenience. In terms of application, Type 1 and Type 2 diabetes management accounts for the bulk of device utilization, while gestational diabetes monitoring underscores a growing need for maternal-fetal health solutions. Distribution channels range from manufacturer websites and third-party e-commerce platforms to hospital, online, and retail pharmacies, each offering unique opportunities for direct-to-consumer engagement and institutional procurement.

Regional Dynamics Fueling Opportunities Across the Globe

Regional dynamics play a pivotal role in shaping both demand and competitive intensity within the smart blood glucose monitoring market. The Americas continue to lead in technology adoption, driven by established reimbursement frameworks, robust payer systems, and widespread digital health infrastructure. In Europe, the amalgamation of Middle East & Africa markets reveals diverse regulatory landscapes and variable access to remote monitoring, prompting manufacturers to tailor product portfolios to local clinical guidelines and cost environments. Meanwhile, the Asia-Pacific region is witnessing accelerated uptake fueled by rising diabetes prevalence, expanding primary care networks, and government initiatives to integrate telemedicine into public health strategies. Each region’s unique combination of healthcare policies, economic factors, and patient preferences defines its growth trajectory and investment priorities.

Leading Innovators Shaping the Competitive Terrain

The competitive field is characterized by a mix of established leaders and agile innovators that drive continuous improvement in device performance, patient experience, and data analytics capabilities. Market incumbents have reinforced their positions through strategic alliances, extended clinical trials, and integration with digital health ecosystems. At the same time, emerging companies are unlocking niche segments by focusing on non-invasive sensor research, developing advanced algorithms for predictive glycemic modeling, and offering differentiated service packages for remote patient management. Collaboration between device manufacturers and software developers has led to unified platforms that deliver end-to-end solutions, while partnerships with academic institutions and healthcare systems ensure rigorous clinical validation and real-world evidence generation. This interplay between legacy expertise and disruptive ingenuity is setting new benchmarks for accuracy, convenience, and patient engagement.

Strategies for Industry Leaders to Capitalize on Emerging Trends

Industry leaders must adopt a multifaceted strategy to capitalize on the evolving market dynamics. Prioritizing interoperability across devices and electronic health record systems will strengthen clinical workflows and unlock new revenue streams through value-based care models. Expanding localized manufacturing and forging regional partnerships will mitigate tariff exposure and ensure supply continuity. Moreover, investing in minimally invasive and non-invasive research, while advancing predictive analytics for personalized therapy, will differentiate offerings in a crowded marketplace. Finally, enhancing direct-to-patient engagement via omnichannel distribution strategies and digital coaching services will foster adherence, elevate brand loyalty, and drive sustainable growth.

Rigorous Research Methodology Underpinning Our Analysis

This analysis is grounded in a rigorous research framework that synthesizes extensive secondary and primary data sources. Comprehensive desk research included a deep dive into peer-reviewed journals, regulatory filings, patent databases, and company disclosures to map technological advancements and competitive maneuvers. Primary research comprised structured interviews with industry stakeholders, including device manufacturers, healthcare providers, payers, and patient advocacy groups, to glean insights on adoption barriers and unmet needs. Data triangulation and validation processes ensured consistency and accuracy, while thematic analysis techniques distilled complex information into actionable intelligence. The result is a robust evidence base that underpins strategic recommendations and sheds light on emerging growth levers.

Converging Insights and Strategic Imperatives

In conclusion, the smart blood glucose monitoring landscape is poised for sustained transformation as technology convergence, regulatory evolution, and shifting patient expectations redefine diabetes care. Companies that can adapt to tariff headwinds, leverage segmentation insights, and tailor solutions to regional nuances will gain a competitive edge. The strategic imperatives identified in this report offer a roadmap for innovators to enhance patient outcomes, streamline clinical workflows, and unlock new market opportunities. By synthesizing deep domain expertise with actionable data, this executive summary equips decision-makers with the intelligence needed to navigate complexity and drive growth in an increasingly connected healthcare ecosystem.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Continuous Glucose Monitoring Systems
      • Dexcom G6
      • FreeStyle Libre
      • Medtronic Guardian
    • Receivers
    • Self-Monitoring Blood Glucose Devices
      • Glucometers
      • Test Strips
    • Sensors
    • Transmitters
  • End User
    • Ambulatory Care Centres
    • Diagnostic Centres
    • Home Usage
      • Adult Use
      • Pediatric Use
    • Hospitals & Clinics
  • Technology
    • Invasive
    • Minimally Invasive
    • Non-Invasive
  • Application
    • Gestational Diabetes
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Distribution Channel
    • E-Commerce
      • Manufacturer Websites
      • Third-Party Platforms
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Dexcom, Inc.
  • Abbott Laboratories
  • Medtronic Plc
  • F. Hoffmann-La Roche Ltd
  • Ascensia Diabetes Care Holdings AG
  • LifeScan Scotland Ltd
  • Nipro Corporation
  • Arkray, Inc.
  • Senseonics Holdings, Inc.
  • AgaMatrix, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Smart Blood Glucose Monitoring Device Market, by Product Type
8.1. Introduction
8.2. Continuous Glucose Monitoring Systems
8.2.1. Dexcom G6
8.2.2. FreeStyle Libre
8.2.3. Medtronic Guardian
8.3. Receivers
8.4. Self-Monitoring Blood Glucose Devices
8.4.1. Glucometers
8.4.2. Test Strips
8.5. Sensors
8.6. Transmitters
9. Smart Blood Glucose Monitoring Device Market, by End User
9.1. Introduction
9.2. Ambulatory Care Centres
9.3. Diagnostic Centres
9.4. Home Usage
9.4.1. Adult Use
9.4.2. Pediatric Use
9.5. Hospitals & Clinics
10. Smart Blood Glucose Monitoring Device Market, by Technology
10.1. Introduction
10.2. Invasive
10.3. Minimally Invasive
10.4. Non-Invasive
11. Smart Blood Glucose Monitoring Device Market, by Application
11.1. Introduction
11.2. Gestational Diabetes
11.3. Type 1 Diabetes
11.4. Type 2 Diabetes
12. Smart Blood Glucose Monitoring Device Market, by Distribution Channel
12.1. Introduction
12.2. E-Commerce
12.2.1. Manufacturer Websites
12.2.2. Third-Party Platforms
12.3. Hospital Pharmacies
12.4. Online Pharmacies
12.5. Retail Pharmacies
13. Americas Smart Blood Glucose Monitoring Device Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Smart Blood Glucose Monitoring Device Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Smart Blood Glucose Monitoring Device Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Dexcom, Inc.
16.3.2. Abbott Laboratories
16.3.3. Medtronic Plc
16.3.4. F. Hoffmann-La Roche Ltd
16.3.5. Ascensia Diabetes Care Holdings AG
16.3.6. LifeScan Scotland Ltd
16.3.7. Nipro Corporation
16.3.8. Arkray, Inc.
16.3.9. Senseonics Holdings, Inc.
16.3.10. AgaMatrix, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SMART BLOOD GLUCOSE MONITORING DEVICE MARKET MULTI-CURRENCY
FIGURE 2. SMART BLOOD GLUCOSE MONITORING DEVICE MARKET MULTI-LANGUAGE
FIGURE 3. SMART BLOOD GLUCOSE MONITORING DEVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SMART BLOOD GLUCOSE MONITORING DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DEXCOM G6, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY FREESTYLE LIBRE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY MEDTRONIC GUARDIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY RECEIVERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY GLUCOMETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TRANSMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY AMBULATORY CARE CENTRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DIAGNOSTIC CENTRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY ADULT USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PEDIATRIC USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. CANADA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 65. CANADA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 66. CANADA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. CANADA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 68. CANADA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. CANADA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. CANADA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. CANADA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 75. MEXICO SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. MEXICO SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. MEXICO SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. MEXICO SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. MEXICO SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 118. GERMANY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 120. GERMANY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 121. GERMANY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. GERMANY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 129. FRANCE SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 130. FRANCE SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. FRANCE SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 132. FRANCE SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. FRANCE SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. FRANCE SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. FRANCE SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 145. ITALY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. ITALY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 147. ITALY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 148. ITALY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. ITALY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 150. ITALY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. ITALY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. ITALY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. ITALY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 154. SPAIN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. SPAIN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 156. SPAIN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 157. SPAIN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SPAIN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 159. SPAIN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. SPAIN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SPAIN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SPAIN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 190. DENMARK SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. DENMARK SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 192. DENMARK SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 193. DENMARK SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. DENMARK SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 195. DENMARK SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. DENMARK SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. DENMARK SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. DENMARK SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 208. QATAR SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. QATAR SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 210. QATAR SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 211. QATAR SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. QATAR SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 213. QATAR SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. QATAR SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. QATAR SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. QATAR SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 217. FINLAND SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. FINLAND SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 219. FINLAND SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 220. FINLAND SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. FINLAND SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 222. FINLAND SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. FINLAND SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. FINLAND SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. FINLAND SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 244. EGYPT SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. EGYPT SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 246. EGYPT SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 247. EGYPT SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. EGYPT SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 249. EGYPT SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. EGYPT SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. EGYPT SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. EGYPT SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 253. TURKEY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. TURKEY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 255. TURKEY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 256. TURKEY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. TURKEY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 258. TURKEY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. TURKEY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. TURKEY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. TURKEY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 271. NORWAY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. NORWAY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 273. NORWAY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE DEVICES, 2018-2030 (USD MILLION)
TABLE 274. NORWAY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. NORWAY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY HOME USAGE, 2018-2030 (USD MILLION)
TABLE 276. NORWAY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. NORWAY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. NORWAY SMART BLOOD GLUCOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. NORWAY SMART BLOOD GLUCOSE M

Companies Mentioned

The companies profiled in this Smart Blood Glucose Monitoring Device market report include:
  • Dexcom, Inc.
  • Abbott Laboratories
  • Medtronic Plc
  • F. Hoffmann-La Roche Ltd
  • Ascensia Diabetes Care Holdings AG
  • LifeScan Scotland Ltd
  • Nipro Corporation
  • Arkray, Inc.
  • Senseonics Holdings, Inc.
  • AgaMatrix, Inc.

Methodology

Loading
LOADING...